Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Prostate Cancer
  •  Radiation Oncology
  •  Ovarian Cancer
  •  Urological Cancers
  •  Cervical Cancer
  •  Stomach Cancer
  •  Lung Cancers
  •  Bladder Cancer


Citation: Clin Oncol. 2024;9(1):2064.DOI: 10.25107/2474-1663.2064

Targeting DNA Damage and Repair (DDR) Pathways: Advances in Understanding and Therapeutic Implications

Mudasir Rashid, Rumaisa Rashid, Deverapalli M, Farjana N, Swetha MA, Brim H and Ashktorab H

Department of Medicine and Cancer Center, Howard University College of Medicine, USA

*Correspondance to: Hassan Ashktorab 

 PDF  Full Text Research Article | Open Access


DNA Damage and Repair (DDR) is a complex and dynamic process that takes care for damaging events occurs in all living organisms. DDR pathways are essential for maintaining genome integrity and preventing the accumulation of mutations that can lead to cancer development. This review comprehensively covers the different DDR pathways includes Base Excision Repair (BER), Nucleotide Excision Repair (NER), Homologous Recombination Repair (HRR), Non- Homologous End Joining (NHEJ), and Mismatch Repair (MMR); key genes involved in DDR pathway (BRCA1/2, ATM, CHEK1/2, MSH2/6, ATR, MDM2); DNA damaging agents (endogenous and exogenous), advancement in targeting the Inhibitors (PARP, ATM and CHEK1 Inhibitors) against DDR genes; and their limitations. Furthermore, detailed challenges and promise of using DDR Inhibitors and future prospective were discussed. Based on the current evidence further research is required to overcome limitations of DDR inhibitors and their specific uses for specific cancer.


DNA Damage and Repair (DDR) pathways; Key DDR genes, DDR Inhibitors

Cite the Article:

Rashid M, Rashid R, Deverapalli M, Farjana N, Swetha MA, Brim H, et al. Targeting DNA Damage and Repair (DDR) Pathways: Advances in Understanding and Therapeutic Implications. Clin Oncol. 2024;9:2064..

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Clinical Features and Gene Mutations of Disseminated Intravascular Coagulation Patients in Acute Promyelocytic Leukemia
 Abstract  PDF  Full Text
Charlson Comorbidity Index as a Predictor of Cancer Mortality Beyond 10 Years after Radical Prostatectomy
 Abstract  PDF  Full Text
View More...